World News Insights
1-3 Minute Gist
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
All Topics Article
Democrats Say No to Cost Cap for Drug Makers
Keywords:
Tags:
Meeting the cost concerns of governments and insurers. Efforts by pharmaceutical companies.
11/09/2006
Efforts by companies like GlaxoSMithKline to meet cost concerns of governments by linking pricing to the effectiveness of the drugs or treatments. Pharmaceutical pricing an issue with governments.
Grouped Articles
Wall Street Journal 11/09/2006
Glaxo Chief Charts New Growth Strategy
Wall Street Journal 06/10/2008
Pricey Drugs Put Squeeze on Doctors
Wall Street Journal 07/08/2008
Drug Makers Trim Prices for Health Overhaul
Wall Street Journal 06/22/2009
For Drug Makers, Concessions Have a Bright Side
Wall Street Journal 06/23/2009
New York Times 06/25/2009
Pharmaceutical company pricing in the U.S. and Europe
11/09/2007
The pricing of pharmaceutical products and healthcare services in the U.S. and Europe.
Grouped Articles
The Soaring Cost of a Simple Breath
New York Times 10/12/2013
Glaxo Sues Abbott Labs Over AIDS Drug Pricing
Wall Street Journal 11/09/2007
India Prepares EU Trade Complaint
Wall Street Journal 08/06/2009
Democrats Say No to Cost Cap for Drug Makers
New York Times 08/07/2009
Economist 08/27/2009
Large Price Jumps Reported for Small but Vital Drugs
New York Times 01/11/2010
Innovation and the pricing of drugs in the U.S. by the pharmaceutical companies.
06/09/2007
Will drug innovation be affected adversely by price reductions in the USA? No say experts as it is a globalized industry and innovation takes place in labs around the world. And the pricing reforms, as in Britian and Germany, can actually encourage R&D for effective drugs with good cost relationships; when comparitive effectiveness of drugs and cost benefit analyses is used in pricing reforms. Pricing of pharmaceutical products and healthcare services is the major unsolved problem in the U.S.
Grouped Articles
The Soaring Cost of a Simple Breath
New York Times 10/12/2013
New Medicines Emerge, but Few Blockbusters
Wall Street Journal 12/16/2013
New York Times 12/21/2013
FDA Approves Cholesterol Drug From Regeneron, Sanofi
Wall Street Journal 07/25/2015
Washington Post 09/22/2015
Settlement May Cut Drug Prices
Wall Street Journal 06/09/2007
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us